A61P 15 - Drugs for genital or sexual disorders; Contraceptives

Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/2001
11/08/2001	US20010039296 Method and composition for preventing or reducing the symptoms of menopause
11/08/2001	US20010039289 Antagonists; especially sodium salts
11/08/2001	US20010039285 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
11/08/2001	US20010039280 Optically active 3-[(2-Piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-HT 1D receptor selective antagonists
11/08/2001	US20010039271 For treatment of male erectile dysfunction, female sexual dysfunction
11/08/2001	US20010039257 Augmenting actions of cAMP in an effector system while reducing cAMP action in a nociceptive system comprising application of one or more forms of nitrogen oxide or carbon monoxide to a site wherein cAMP exists
11/08/2001	CA2408105A1 Novel proteases
11/08/2001	CA2407965A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	CA2407746A1 Proteases
11/08/2001	CA2407604A1 Splice variant of camp phosphodiesterase type 7 (pde7a3)
11/08/2001	CA2407597A1 Tricyclic fused pyridine and pyrimidine derivatives as crf receptor antagonists
11/08/2001	CA2407418A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001	CA2407317A1 Dihydropyridine compounds and methods of use
11/08/2001	CA2405745A1 New betamimetics having a long-lasting activity, processes for preparingthem and their use as medicaments
11/08/2001	CA2404936A1 (5r)-(methylamino)-5,6-dihydro-4h-imidazo¬4,5,1-ij\|quinoline-2(1h)-thione
11/07/2001	EP1152060A1 5T4 tumour-associated antigen for use in tumour immunotherapy
11/07/2001	EP1152055A1 ADAMTS polypeptides, nucleic acids encoding them, and uses therof
11/07/2001	EP1151756A1 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus
11/07/2001	EP1150993A1 Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
11/07/2001	EP1150979A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
11/07/2001	EP1150978A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone
11/07/2001	EP1150963A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
11/07/2001	EP1150960A1 Polymorphic crystalline forms of celecoxib
11/07/2001	EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability
11/07/2001	EP1150950A2 Anthranilic acid derivatives
11/07/2001	EP1150712A2 Human papilloma virus vaccine formulations
11/07/2001	EP1150698A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction
11/07/2001	EP1150687A2 Methods for anti-tumor therapy
11/07/2001	EP1150683A1 Utilization of dienogest in high doses
11/07/2001	EP1150676A1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
11/07/2001	EP1150658A2 Method for controlling liposome size
11/07/2001	EP1150630A1 Prolonged release bioadhesive vaginal gel dosage form
11/07/2001	EP1150574A1 A natural tea for curing men's impotence and a method for manufacturing the same
11/07/2001	EP0758452B1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same
11/07/2001	CN1321158A Tricyclic delta 3-piperidines as pharmaceuticals
11/07/2001	CN1321086A Mucosal originated drug delivery system and animal applications
11/07/2001	CN1320457A Wet tissue with disinfecting medicine and sterilizing powder
11/07/2001	CN1320454A Capsule for treating threatened abortion and habitual abortion
11/07/2001	CN1320451A Exterior-applied medicine for treating gynopathy
11/07/2001	CN1320426A Compound for treatment of female sexual dysfuction
11/07/2001	CN1074279C Estradiol benzoate gel agent and its preparing method
11/07/2001	CN1074278C Process for producing sterile freeze-dried prostaglandin E1 powder injection
11/06/2001	US6313312 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy
11/06/2001	US6313308 Methods for the preparation of biphenyl isoxazole sulfonamides
11/06/2001	US6313298 Spiro-indolines as Y5 receptor antagonists
11/06/2001	US6313180 Steroid compounds having contraceptive and anti-osteoporosis activity
11/06/2001	US6313160 Substituted heterocyclic compounds, method for preparing and compositions containing same
11/06/2001	US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
11/06/2001	US6313118 Hydroxytryptamine receptor antagonists
11/06/2001	US6313108 Treating androgen insufficiency
11/06/2001	US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/01/2001	WO2001081928A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
11/01/2001	WO2001081577A2 Dna encoding the prost 03 polypeptide
11/01/2001	WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	WO2001081540A2 Growth factor which acts through erb b-4 rtk
11/01/2001	WO2001081363A1 Novel compounds
11/01/2001	WO2001081337A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001081314A1 Naphthamidine urokinase inhibitors
11/01/2001	WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001	WO2001081304A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001080937A1 Drug delivery device for insertion in the vagina, rectum or nasal cavity
11/01/2001	WO2001080860A2 Daily treatment for erectile dysfunction using a pde5 inhibitor
11/01/2001	WO2001080845A2 (2-aminoethyl) oxime derivatives for the treatment of depression
11/01/2001	WO2001044239A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
11/01/2001	WO2001041762A3 Valdecoxib compositions
11/01/2001	WO2001041761A3 Valdecoxib compositions
11/01/2001	WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2
11/01/2001	WO2001029015A3 Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
11/01/2001	WO2001021620A3 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines
11/01/2001	US20010036456 Administering Protein C
11/01/2001	US20010036451 Embolic compositions
11/01/2001	CA2407663A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	CA2407662A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	CA2407519A1 Daily treatment for erectile dysfunction using a pde5 inhibitor
11/01/2001	CA2407449A1 Novel compounds
11/01/2001	CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	CA2405680A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
11/01/2001	CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001	CA2405025A1 (2-aminoethyl) oxime derivatives for the treatment of depression
10/2001
10/31/2001	EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001	EP1149579A2 Use of an estrogen agonist/antagonist for treating female sexual dysfunction
10/31/2001	EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001	EP1149083A1 Morpholinobenzamide salts
10/31/2001	EP1148888A2 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
10/31/2001	EP0811001B1 Benzothiazine dioxides as endothelin antagonists
10/31/2001	CN1319429A Medicine for treating female metrorrhagia and metrostaxis and preparation method thereof
10/31/2001	CN1319417A Medicine for treating menopausal syndrome and preparation process thereof
10/31/2001	CN1073988C Substituted N-heteroaroylguanidin, preparation, pharmaceutical application and medicine containg same
10/30/2001	US6310063 Aminoalkyl substituted pyrrolo [3,2-E]pyridine and pyrollo [2,3-b]pyrimidine derivatives: modulators of CRF1 receptors
10/30/2001	US6310050 Therapeutic use of compounds with β3-agonist activity
10/30/2001	US6309856 Human MAD proteins and uses thereof
10/30/2001	US6309854 Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
10/27/2001	CA2345180A1 Methods of treating obesity using a neurotensin receptor ligand
10/25/2001	WO2001079524A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof
10/25/2001	WO2001079480A1 Albumin fusion proteins
10/25/2001	WO2001079455A1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/25/2001	WO2001079444A2 Albumin fusion proteins
10/25/2001	WO2001079443A2 Albumin fusion proteins
10/25/2001	WO2001079442A2 Albumin fusion proteins
10/25/2001	WO2001079283A1 Modulating cell survival by modulating huntingtin function

1 ... 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 ... 557